vipidia
takeda pharma a/s - alogliptin - diabetes mellitus, typ 2 - drugs used in diabetes, dipeptidyl peptidase 4 (dpp-4) inhibitors - vipidia je indikovaná u dospelých vo veku 18rokov a starších s diabetom mellitus 2. typu na zlepšenie kontroly glykémie v kombinácii s iným liekom vrátane inzulínu, keď tieto spolu s diétou a cvičením neposkytujú dostatočné na zníženie glukózy glykemickú kontrolu (pozri časti 4. 4, 4. 5 a 5. 1 pre dostupné údaje o rôznych kombináciách).
controloc 40 mg
takeda gmbh, nemecko - pantoprazol - 09 - antacida (vrÁtane antiulcerosnych lieČiv)
controloc i.v.
takeda gmbh, nemecko - pantoprazol - 09 - antacida (vrÁtane antiulcerosnych lieČiv)
controloc 20 mg gastrorezistentné tablety
takeda gmbh, nemecko - pantoprazol - 09 - antacida (vrÁtane antiulcerosnych lieČiv)
xefo rapid
takeda pharma a/s, dánsko - lornoxikam - 29 - antirheumatica, antiphlogistica, antiuratica
xefo 8 mg filmom obalené tablety
takeda pharma a/s, dánsko - lornoxikam - 29 - antirheumatica, antiphlogistica, antiuratica
xefo 4 mg filmom obalené tablety
takeda pharma a/s, dánsko - lornoxikam - 29 - antirheumatica, antiphlogistica, antiuratica
xefo 4 mg/ml
takeda pharma a/s, dánsko - lornoxikam - 29 - antirheumatica, antiphlogistica, antiuratica
alunbrig
takeda pharma a/s - brigatinib - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.
qdenga
takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - tropická horúčka - vakcíny - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.